Moderna Stock

Moderna Goodwill/Assets

The Goodwill to Total Assets Ratio of Moderna (MRNA) as of Aug 11, 2026 is 0.42 %. In the previous year, Goodwill to Total Assets Ratio was 0.37 % — a change of 14.62% (higher).

Goodwill/Assets

0.42 %

YoY

14.62%

Last updated:

Goodwill to Total Assets Ratio of Moderna is 2026 0.42 % . Goodwill to Total Assets Ratio of Moderna was 2025 0.37 % . It decreases by 14.62% higher compared to the previous year.
Access this data via the Eulerpool API

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

Goodwill to Total Assets Ratio of Moderna is 0.42 % in 2026.

Goodwill to Total Assets Ratio of Moderna changed from 0.37 % to 0.42 %, representing a 14.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Moderna since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Moderna historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Moderna

All Key Metrics — Moderna